A study to evaluate two drugs, Panchatikta Ghrita and Nalpamaradi Taila in patients with Vicharchika(Eczema)
- Conditions
- Health Condition 1: L309- Dermatitis, unspecified
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 120
1.Patients of either sex with age between 18 and 60 years
2.Known cases of eczema (based on Hanifin and Rajka Criteria
for Atopic Dermatitis/ Atopic Eczema).
3.Patients willing and able to participate in the study
1.Patient with Status Eczematous condition.
2.Patient with poorly controlled Hypertension ( >160/100 mmHg)
3.Patient with uncontrolled Diabetes Mellitus having HbA1C > 8%
4.Patient on medication with corticosteroids, phototherapy,
biologics, antidepressants and any other drugs that may
have an influence on the outcome of the study.
5.Alcoholic and/or drug abuser
6.Symptomatic patients with clinical evidence of heart failure.
7.Known case of HIV and AIDS.
8.Known case of Malignacy.
9.Patienttaking participation in any other clinical trial.
10.Woman who are planning for conception/pregnant or lactating.
11.Patientwith concurrent serious hepatic disorders (defined as aspartate amino (AST) and/ or Alanine AminoTransferase(ALT) >2times upper normal limit or Renal Disorders (defined as S. Creatinine >1.2mg/dl), Severe pulmonary Dysfunction (uncontrolled Bronchial Asthma and /or Chronic obstructive Pulmonary Disease (COPD).
12.H/o hypersensitivity to any of the trial drugs or their ingredients.
13.Patient who have completed participation in any other
clinical trial during the past three months.
14.Any other condition which the Investigator thinks may
jeopardize the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in Eczema Area Severity Index score (EASI) <br/ ><br>Change in Patient Oriented Eczema measure (POEM) <br/ ><br>Change in Dermatology life Quality Index (DLQI ) Questionnaire score <br/ ><br>Timepoint: At Baseline, 14th day, 28th day, 42th day, 56th day, 70th day, 84th day and 112th day
- Secondary Outcome Measures
Name Time Method Change in Signs & Symptoms.Timepoint: At Baseline, 14th day, 28th day, 42th day, 56th day, 70th day, 84th day and 112th day